Cell Medica, Inc.
Records under this name other than the patents Cell Medica, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,005,924 | Acceptor Framework for CDR Grafting Formerly held In force · High confidence | In force | High confidence | |
| US 9,051,366 | Acceptor Framework for CDR Grafting Formerly held In force · High confidence | In force | High confidence | |
| US 11,155,784 | Process of Expanding T Cells Formerly held In force · High confidence | In force | High confidence | |
| US D820,996 | Cell culture pot Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,963,979 | Process for T Cell Expansion Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,221,391 | Device for the Aseptic Expansion of Cells Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,077,302 | Method of Inhibiting Human IL-1 Beta by Administering an Antibody to Human IL-1 Beta Lapsed on the fee record Ended Sep 18, 2026 · High confidence | Lapsed on the fee record | Ended Sep 18, 2026 | High confidence |
| US 11,434,294 | Binding Members to PD-L1 Lapsed on the fee record Ended Sep 6, 2026 · High confidence | Lapsed on the fee record | Ended Sep 6, 2026 | High confidence |
| US 11,407,824 | Nucleic Acids Encoding Antibodies Against IL-1 Beta Lapsed on the fee record Ended Aug 9, 2026 · High confidence | Lapsed on the fee record | Ended Aug 9, 2026 | High confidence |
| US 9,994,645 | Acceptor Framework for CDR Grafting Formerly held Lapsed on the fee record Ended Jun 12, 2026 · Low confidence | Lapsed on the fee record | Ended Jun 12, 2026 | Low confidence |